This PCORI funding opportunity is currently closed.

PCORI seeks to fund large high-quality studies that respond to the following priority question:

What is the comparative effectiveness of psychosocial interventions versus standard medical management for patients who receive office-based opioid treatment with buprenorphine?

PCORI is especially interested in stepped-care and needs-based approaches rather than straightforward comparisons of interventions. All comparators should be clearly defined, evidence-based or in clinical use, and be, or be able to be made, widely available. While randomized controlled trials (RCTs) are preferred, well-designed comparative observational studies and natural experiments of established programs may also be proposed.

Applicants should justify their patient populations of interest (e.g., urban, rural, low-income, and/or racial and ethnic minorities). PCORI is particularly interested in applications that focus on or include urban, low-income, and/or racial-ethnic minority populations. Proposals should have strong endorsement and study participation by patient organizations, professional organizations, payer or purchaser organizations, and other relevant stakeholder groups.

Download Full Announcement

Key Dates

Online System Opens:
Letter of Intent Deadline:
Application Deadline:

Funds and Project Period

Funds Available Up To

$25 million

Total Direct Costs

$4 million

Maximum Project Period

4 years


Award Types